SUMMARY
Group I. Atracurium bolus: an initial dose of atracurium 0.6 mg kg" 1 followed by bolus doses of 0.15 mg kg" 1 given 30 min after the first dose and every 20 min thereafter.
Group II. Atracurium infusion: an initial dose of atracurium 0.6 mg kg" 1 followed by an infusion of 0.45 mg kg" 1 h" 1 started 10 min after the bolus dose. fusion of 0.08 mg kg" 1 h" 1 started 10 min after the bolus dose.
Group V. Control group: these patients received no neuromuscular blocking drugs and maintained spontaneous ventilation.
The doses of drug were based on data sheet recommendations and were chosen to give approximately the same total dose of drug by both methods of administration over a period of 90 min: atracurium 1.2 mg kg" 1 by both methods and vecuronium 0.22 mg kg" 1 . The doses of atracurium and vecuronium were considered to be equipotent.
Anaesthesia
All patients received temazepam 20 mg by mouth as premedication. Anaesthesia was induced with thiopentone 4-5 mg kg" 1 i.v. and fentanyl 100 ug and maintained with 0.5-1 % isoflurane (groups I-IV) or 1-2% isoflurane (group V) and 66% nitrous oxide in oxygen. Neuromuscular block was antagonized with neostigmine 2.5 mg given with atropine 1.2 mg. Postoperative analgesia (papaveretum 10-20 mg i.m.) was prescribed on demand for all patients.
Intraoperative observations
Neuromuscular transmission was monitored throughout the operation in groups I-IV using the Datex Relaxograph. The Relaxograph was calibrated for each patient following induction of anaesthesia and before administration of the neuromuscular blocking drug. The initial twitch height (Tl %) and train-of-four ratio (TOF ratio) were recorded at 5-min intervals from the administration of the initial dose. The duration of infusion, total number of increments and time from discontinuation of infusion or from last increment to administration of neostigmine were recorded. The Tl % and TOF ratio were recorded at administration of antagonizing agents and at 1-min intervals until the trachea was extubated.
Assessment of recovery of neuromuscular function
The patients' grip strength and respiratory function were measured after operation and compared with the pre-anaesthesia values. The day before surgery the patient had been visited and the study explained. At this time the patient was familiarized with the equipment to be used after operation and a practice series of three readings was taken. Grip strength of the dominant hand was measured using a compressible oil-filled cylinder with a Bourdon gauge ( fig. 1 ). Respiratory function was measured with a spirometer (MicroMedics) and peak expiratory flow (PEF), forced expired volume in 1 s (FEV t ) and forced vital capacity (FVC) recorded. Three readings were taken for each test. PEF and FVC were measured separately. All measurements were made with the patient supine. On the day of surgery, following premedication, the measurements were repeated. The mean value for grip strength and the best value for the respiratory variables were used as control values for the postoperative study.
Grip strength and PEF were measured on each patient at 15-min intervals for 90min after surgery. The first measurements were made 15 min after the neostigmine-atropine was given (groups I-IV) or 15 min after discontinuation of the isoflurane (group V). FVC and FEVj were measured at 90 min.
All the intraoperative and postoperative observations were made by the same observer who was blinded to which agent was used, but not to the method of administration.
Data from the five groups were compared using analysis of variance (ANOVA). Where ANOVA showed significant difference between the groups, one-way analysis of variance with Tukey's HSD test was used. Where appropriate, Student's t test was used to compare data within each group.
RESULTS
There were no significant differences between the groups with respect to age, weight, sex or duration of operation (table I) . In group II the mean time from end of infusion to administration of neostigmine was 10.8 (2.2) min and in group IV it was 11.3 (2.0) min (ns).
In group I, two patients received one increment, four received two and four received three increments of atracurium (mean 2.2). In group III, one patient received one increment, three received two, and six received three increments of vecuronium (mean 2.5). There was no significant difference in the number of increments given. In group I the mean time from last increment to antagonism of block was 21.2 (5.3) min and in group III it was 21.0 (5.6) min (ns).
The median and range of Tl % for groups I-IV taken at 10-min intervals during the first 1 h of anaesthesia are shown in table II. There was no significant difference in the degree of block achieved between the two infusion groups or between the two bolus groups. As would be expected, there was more variation within the bolus dose groups than within the infusion groups.
There was no significant difference in twitch height (Tl %) at the time of reversal between the groups (table III) trachea, and the Tl % and TOF ratio at time of extubation were not significantly different.
Grip strength
Comparison of grip strength within each group demonstrated a significant decrease from control (preoperative) up to 45 min in group I, up to 30 min in groups III and V, but only at 15 min in groups II and IV (table IV) .
The grip strength at 15 min after antagonism of blockade was significantly less (P < 0.01) in group IV (vecuronium infusion) (48 (4.6) % of control) compared with group I (76.4 (8.0)%), group II (76.6 (7.0) %) and group V (79.5 (6.3) %), but not with group III (63.8 (6.9)%). There were no significant differences between the groups from 30 to 90 min.
Peak expiratory flow
In group V (spontaneous ventilation) PEF was significantly reduced from control value only at 15 and 30 min (P < 0.01) (table V). A statistically significant reduction was still present in groups I-IV at 90 min. In the atracurium groups, PEF was greater than 90 % of control by 60 min (bolus) and 45 min (infusion). In the vecuronium groups PEF had not achieved 90% by 90 min. This difference was not significant statistically. PEF at 15 min was significantly less (P < 0.05) in group IV (41.0 (8.3)%) compared with group I (70.0 (3.3)%). There were no significant differences between the groups from 30 to 90 min.
FVC and FEVj measured at 90 min after antagonism of blockade demonstrated no significant difference between the groups and no significant difference from the preoperative values.
There was no significant correlation between twitch height at antagonism of block and either the grip strength or PEF at 15 min. There was a significant correlation between grip strength at 15 min and PEF at 15 min (r = 0.582, P < 0.001).
Postoperative analgesia was required in nine patients (three in group I, two in each of groups II and IV and one in each of groups III and V). In all these patients analgesia was given at 30-60 min.
DISCUSSION
Administration of the same dose of neuromuscular blocking drug by infusion or by repeat bolus injections produced a similar degree of neuromuscular block during surgery. A slower initial recovery of function was found after vecuronium infusion than after vecuronium bolus.
A similar degree of block was achieved during operation between the two bolus dose groups and also between the two infusion groups. This suggests that the doses of atracurium and vecuronium used in this study were equipotent. The ratio of total doses used is in agreement with published potency ratios for atracurium and vecuronium, approximately 5:1 [2, 3] .
The difference in the initial recovery of both PEF and grip strength cannot be explained by differences in the time from administration of the last increment or discontinuation of the infusion until antagonism of neuromuscular block, as there was no difference between the groups in the twitch height at antagonism. However, there was no correlation between the twitch height at antagonism of block and either PEF or grip strength. This is in agreement with the findings of Noeldge and colleagues [4] who found no correlation between twitch height at reversal and the time for 25-75 % recovery of twitch height.
It has been suggested that grip strength is a more sensitive measure of residual neuromuscular block than is ventilatory function testing [5, 6] . Grip strength testing requires less patient cooperation, has the advantage of being less uncomfortable than continuation of train-of-four stimulation into the postoperative period and, unlike ventilatory function testing, is not restricted by postoperative pain. The findings of our study are in agreement with a recent investigation which compared the recovery after atracurium or pancuronium and demonstrated that grip strength recovered more quickly than expiratory force [7] . This effect was more evident following pancuronium.
Some of the initial effect on grip strength and PEF must be attributed to the sedative effect of anaesthesia, as shown by the decreases in the group which received no neuromuscular block (group V). This group, however, received a higher concentration of isoflurane (1-2%) than the other groups (0.5-1 %), who received similar concentrations of isoflurane. The differences in the clinical tests of recovery may be attributed to differences between the groups in the recovery from neuromuscular block.
The PEF at 15 min after operation was lower, but not significantly, in the groups receiving neuromuscular blocking drug by infusion than in those receiving bolus doses, despite similar twitch heights at the time of antagonism. This was more marked with vecuronium. The difference in the time course of recovery following atracurium or vecuronium may be explained in part by the differences in pharmacokinetic properties between the two drugs [8] . The difference noted between recovery from the same total dose given by infusion or by bolus dosing is more difficult to explain. Our findings are in agreement with previous studies using the 25-75 % twitch height recovery time as a measure of recovery. These studies have demonstrated no increase in this time following atracurium infusion [9, 10] , but a prolongation following vecuronium infusion [4] when compared with that following administration of bolus doses of each agent.
